Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Augmentin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Augmentin 625mg tablets
0501013K0BBALAJ
|
Augmentin | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 1,001 |
|
Augmentin 375mg tablets
0501013K0BBAAAA
|
Augmentin | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 280 |
|
Augmentin 250/62 oral suspension
0501013K0BBANAI
|
Augmentin | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 89 |
|
Augmentin 125/31 oral suspension
0501013K0BBAPAH
|
Augmentin | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 40 |
|
Augmentin-Duo 400/57 oral suspension
0501013K0BBAQAP
|
Augmentin | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 30 |
|
Augmentin Intravenous 1.2g inj vials
0501013K0BBAHAF
|
Augmentin | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 1 |
|
Augmentin Intravenous 600mg inj vials
0501013K0BBACAE
|
Augmentin | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 1 |
|
Augmentin 375mg dispersible tablets
0501013K0BBABAB
|
Augmentin | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.